Analyst	Recommendation	Action	Price target	Projected	Date
Stephen Scouten Piper Sandler	Buy	Reiterated	$46.00	+10.8%	10/20/2026
Michael Rose Raymond James	Buy	Maintained	$45.00	+8.4%	10/06/2026
Steve Moss Raymond James	Buy	Maintained	$45.00	+8.4%	10/06/2026
David Bishop Hovde Group	Buy	Upgraded	$89.00	+114.5%	12/19/2025

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	152.93M	148.35M	157.12M	157.68M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	37.99M	40.27M	40.43M	40.34M
Operating expense	42.15M	44.62M	47.13M	49.28M
Total operating expenses	42.15M	44.62M	47.13M	49.28M
Operating income	110.78M	103.73M	109.98M	108.41M
Other non operating income	-2.65M	-2.76M	-2.83M	-2.95M
EBT including unusual items	107.61M	100.97M	107.16M	105.45M
EBT excluding unusual items	108.12M	100.97M	107.16M	105.45M
Income tax expense	21.22M	18.00M	21.36M	18.14M
Effective tax rate	19.72%	17.82%	19.94%	17.21%
Other operating expenses	4.17M	4.35M	6.71M	8.94M
Net income	86.38M	82.97M	85.79M	87.31M
Net profit margin	56.49%	55.93%	54.60%	55.37%
Earnings per share	0.79	0.76	0.78	0.80
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-1.62M	-1.82M	-2.11M	-1.59M

Ask anything